The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension
Abstract
Summary: OBJECTIVE 11 β‐Hydroxysteroid dehydrogenase protects renal mineralocorticoid receptors from Cortisol by converting Cortisol to inactive cortisone. 11 β‐Dehydrogenase deficiency, either congenital or after inhibition by liquorice and carbenoxolone, results in cortisol‐dependent mineralocorticoid excess and hypertension. We tested the hypothesis that the same mechanism occurs in some patients with essential hypertension. DESIGN/PATIENTS Twenty patients with essential hypertension were compared with 19 matched healthy controls. MEASUREMENTS 11 β‐Hydroxysteroid dehydrogenase activity was assessed by the half‐life of 11α‐3 H‐cortisol, and by the ratios of Cortisol to cortisone in plasma and of their metabolites in urine. Renal mineralocorticoid receptor activation was assessed by plasma potassium, renin activity and aldosterone. RESULTS Half‐lives of 11α‐3 H‐cortisol were prolonged in a subgroup of hypertensives (mean ± SE 53.2 ± 3.6 min in hypertensives vs 42.3 ± 2.3 in controls,P<0.05; seven of the 20 hypertensives had half‐lives exceeding 2 SD of controls). Ratios of Cortisol to cortisone in plasma and of their metabolites in urine were not different. 11α‐3 H‐Cortisol half‐lives correlated with blood pressure but not with indices of renal mineralocorticoid receptor activation. CONCLUSIONS 11 β‐Dehydrogenase is defective in a proportion of patients with essential hypertension. The normal ratios of Cortisol to cortisone in plasma and of their metabolites in urine, also seen after carbenoxolone administration, suggest that 11 β‐reductase conversion of cortisone to Cortisol is also defective. Unlike other syndromes of 11 β‐dehydrogenase deficiency, the defect was not associated with mineralocorticoid excess. We suggest that it may cause hypertension by increasing exposure of vascular steroid receptors to Cortisol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
Agarwal, A. K., Monder, C., Eckstein, B., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47248-7 · Cited by 455
Cited by
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731
Self-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationSeckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Self-citationHuman hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C. (1995) · Nature Genetics · doi:10.1038/ng0895-394 · Cited by 619
Metadata
- Authors
- Walker, B. R., Stewart, P. M., Shackleton, C. H. L., Padfield, P. L., & Edwards, C. R. W.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1993-08
- Volume
- 39
- Issue
- 2
- Pages
- 221-227
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2046793114
- Cited by
- 174
- References
- 2
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension. https://app.cochat.ai/papers/10.1111/j.1365-2265.1993.tb01778.x
- The paper
- Walker, B. R., Stewart, P. M., Shackleton, C. H. L., Padfield, P. L., & Edwards, C. R. W. (1993). Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1993.tb01778.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.